{IMAGERIGHT:http://www.massdevice.com/sites/default/wp-content/uploads/checkup/090630_index1.jpg}Our Weekly Checkup takes the temperature of the more than 60 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
The index for the week ended June 26 closed at 5.49, up 1 percent compared with the prior week but down sliver since Jan. 1, when we began tracking these companies.
Generally speaking, the MassDevice index seems to track four other indices (the S&P 500, the Dow Jones Industrial Average, the Dow’s IHI medical devices index and the NASDAQ exchange):
{IMAGE:http://www.massdevice.com/sites/default/wp-content/uploads/checkup/090630_index2.jpg}
The Weekly Checkup also compares Monday morning’s opening share prices with their value when the markets close Friday afternoon to calculate the biggest gainers and losers.
Here are the ten firms that posted the biggest share price gains and losses during the week ended June 19:
The five biggest gainers:
- Quick-Med Technologies Inc. 34.8% (open $0.46; close $0.62)
- Exact Sciences Corp. 15.3% (open $2.29; close $2.64)
- LeMaitre Vascular Inc. 12.6% (open $3.01; close $3.39)
- HeartWare International Inc. 12.2% (open $24.69; close $27.69)
- Aspect Medical Systems Inc. 12.0% (open $5.48; close $6.14)
And the five biggest losers:
- Acusphere Inc. -26.3% (open $0.19; close $0.14)
- Biopure Corp. -24.1% (open $0.29; close $0.22)
- Implant Sciences Corp. -20.0% (open $0.10; close $0.08)
- Interleukin Genetics Inc. -19.7% (open $0.61; close $0.49)
- NeuroMetrix Inc. -18.7% (open $2.35; close $1.91)
The checkup also takes a look at a different financial metric each week, ranking local players based their performance in that category.
Last week, we examined companies with high selling, general and administrative costs as a percentage of total revenues. It’s a measure of how efficiently a company manages its cash flow; while a high ratio can mean a company’s costs are outstripping its cash intake, a low ratio can mean it’s very efficient at managing cash.
Here are the top 20 public medical device companies in Massachusetts when it comes to low SGA as a percentage of total revenues:
- Dynamics Research Corp.: 9.18
- UFP Technologies Inc.: 17.11
- Charles River Laboratories International Inc.: 17.13
- Parexel International Corp.: 18.18
- MKS Instruments Inc.: 20.22
- American Superconductor Corp.: 20.53
- Brooks Automation Inc.: 21.0
- Bruker Corp.: 22.99
- Hologic Inc.: 24.42
- Thermo Fisher Scientific Inc.: 25.65
- Waters Corp.: 27.09
- Covidien plc: 29.07
- Harvard Bioscience Inc.: 29.65
- Boston Scientific Corp.: 32.16
- Millipore Corp.: 32.25
- SeraCare Life Sciences Inc.: 32.92
- Haemonetics Corp.: 33.24
- Psychemedics Corp.: 35.6
- Zoll Medical Corp.: 35.81
- Caliper Life Sciences Inc.: 36.54
Source: Mergent Inc.
Disclaimer: MassDevice.com’s rankings do not reflect an opinion of companies’ health, prospects or viability. They are intended to provide a snapshot of publicly traded medical device companies and in no way constitute a recommendation to buy or sell any particular security, portfolio of securities, transaction or investment strategy.
